Coroner's concern over woman's fentanyl death

She died after being prescribed fentanyl and codeine for chronic pain, an inquest hears.
Yahoo Finance

Non-Opioid Pain Patch Market Poised for Growth as Innovations and Chronic Pain Prevalence Increase Globally

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Non-Opioid Pain Patch Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The latest comprehensive research on the ...
KTVB

Fentanyl opioid patches recalled for dosing error

Two lots of a transdermal patch used for delivery of the synthetic opioid Fentanyl have been recalled because the patches inside some cartons may contain a different dosage than the carton states. It ...
Seeking Alpha

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Nutriband (NTRB) initiates commercial worldwide brand name development for its lead product, an abuse deterrent transdermal system. Nutriband has partnered with Brand Institute, Inc, the global leader ...
Medscape

Trial Shows Safety, Efficacy of 7-Day Buprenorphine Patch in Opioid-Naive Patients

September 28, 2010 (Las Vegas, Nevada) — A transdermal application system containing the partial μ-opioid receptor agonist buprenorphine showed analgesic efficacy in the treatment of low back pain in ...
Seeking Alpha

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Prescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid ...
WIVB-TV

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American ...

ORLANDO, FL / ACCESSWIRE / March 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that ...